alzheim
diseas
ad
link
increas
mortal
sever
studi
autopsi
studi
dementia
shown
infect
cardiovascular
event
common
caus
death
cancer
less
common
caus
data
suggest
cancer
less
common
patient
diagnos
suspect
suffer
ad
suicid
caus
death
ad
less
investig
well
passiv
form
selfharm
although
small
studi
shown
frequent
patient
ad
current
antipsychot
treatment
patient
diagnos
ad
increas
allcaus
mortal
well
death
specif
caus
eg
cerebrovascular
event
increas
risk
demonstr
use
evid
random
control
trial
nevertheless
studi
shown
benefit
shortterm
antipsychot
treatment
reduc
behaviour
psycholog
symptom
dementia
bpsd
although
studi
long
followup
spars
previous
shown
lifetim
cumul
antipsychot
drug
dosag
allcaus
mortal
associ
suggest
neg
effect
mortal
antipsychot
could
outweigh
effect
antipsychot
bpsd
far
studi
investig
effect
cumul
antipsychot
treatment
patient
diagnos
ad
specif
caus
death
cardiovascular
event
infect
two
common
caus
death
popul
chose
includ
outcom
measur
choic
includ
cancer
undertaken
antipsychot
propos
increas
risk
cancer
develop
cancer
common
caus
background
alzheim
diseas
ad
common
diseas
caus
dementia
link
increas
mortal
howev
effect
antipsychot
use
specif
caus
mortal
yet
investig
thoroughli
method
util
danish
nationwid
regist
defin
cohort
patient
diagnos
ad
util
separ
cox
regress
specif
caus
mortal
investig
effect
cumul
antipsychot
dosag
diagnosi
current
antipsychot
exposur
time
period
result
total
patient
follow
personyear
total
cardiovascular
relat
death
cancer
relat
death
infect
relat
death
intent
selfharm
relat
death
present
current
antipsychot
exposur
increas
mortal
rate
hr
cardiovascular
cancer
infect
relat
death
cumul
antipsychot
dosag
commonli
associ
increas
rate
mortal
cardiovascular
infect
caus
death
wherea
associ
less
clear
cancer
intent
selfharm
caus
death
conclus
show
cumul
antipsychot
drug
dosag
increas
mortal
rate
cardiovascular
infect
caus
death
find
highlight
need
investig
longterm
effect
treatment
possibl
subgroup
could
benefit
treatment
c
elsevi
masson
sa
right
reserv
death
elderli
patient
lastli
chose
includ
intent
selfharm
outcom
rare
would
like
investig
util
larger
dataset
studi
examin
effect
cumul
antipsychot
drug
dosag
well
effect
current
antipsychot
exposur
rate
differ
caus
death
patient
diagnos
ad
nationwid
populationbas
retrospect
cohort
studi
specif
caus
mortal
cardiovascular
cancer
infect
intent
selfharm
patient
diagnos
dementia
ad
form
cohort
newli
diagnos
patient
ad
defin
either
receiv
dementia
alzheim
diseas
alzheim
diseas
diagnosi
pick
prescript
antidementia
drug
atc
januari
decemb
total
danish
popul
person
previous
diagnos
dementia
diagnosi
period
januari
throughout
diagnosi
dementia
period
januari
throughout
exclud
analysi
well
patient
pick
prescript
antidementia
drug
period
januari
decemb
medic
variabl
code
timedepend
variabl
patient
code
nonexpos
first
prescript
antipsychot
defin
atc
exclud
lithium
atc
current
exposur
variabl
base
use
antipsychot
previou
year
group
present
absent
index
defin
prescript
antipsychot
drug
cumul
antipsychot
dosag
dementia
diagnosi
end
studi
particip
calcul
divid
group
baselin
antipsychot
treatment
zero
daili
defin
dosag
ddd
ddd
ddd
ddd
definit
patient
current
expos
antipsychot
could
baselin
cumul
exposur
group
group
defin
arbitrarili
definit
util
similar
studi
current
danish
regist
includ
data
sever
ad
cognit
function
compens
deficit
use
follow
variabl
proxi
marker
diseas
sever
number
psychiatr
bed
day
number
psychiatr
outpati
contact
accommod
statu
diagnosi
marker
examin
incid
dementia
diagnosi
defin
either
diagnosi
first
prescript
antidementia
drug
accommod
statu
dichotom
timedepend
variabl
never
previous
live
institut
live
institut
point
time
diagnosi
defin
psychiatr
comorbid
score
rang
zero
five
determin
aggreg
diagnosi
statu
follow
categori
psychosi
affect
disord
substanc
misus
psychiatr
diagnosi
intent
selfharm
score
comput
patient
could
increas
time
diagnos
given
score
cumul
patient
sinc
initi
danish
psychiatr
central
research
registri
score
previous
util
similar
studi
divid
somat
diseas
follow
group
cardiovascular
diseas
cancer
infect
diabet
epilepsi
lower
respiratori
diseas
somat
diseas
somat
comorbid
score
one
point
ad
diagnosi
group
unless
diagnosi
occur
age
year
male
year
femal
two
point
ad
due
increas
risk
associ
earli
onset
diseas
score
comput
patient
could
increas
time
diagnos
given
score
cumul
patient
sinc
initi
danish
nation
patient
registri
score
previous
util
similar
studi
current
danish
regist
includ
data
blood
pressur
blood
test
result
lipid
glucos
level
besid
gener
practition
examin
treat
major
patient
diagnos
hypertens
increas
lipid
type
ii
diabet
regist
diagnos
danish
regist
make
inform
gap
use
follow
proxi
measur
arteri
hypertens
increas
cholesterol
diabet
data
prescript
antihypertens
drug
atc
drug
use
lower
lipid
atc
drug
treatment
diabet
blood
glucos
lower
drug
excl
insulin
atc
insulin
atc
addit
actual
diagnos
see
somat
comorbid
diseas
medic
variabl
code
timedepend
variabl
patient
code
nonexpos
first
prescript
cox
regress
event
defin
specif
caus
mortal
conduct
use
cumul
antipsychot
dosag
current
antipsychot
exposur
explanatori
variabl
adjust
variabl
defin
variabl
code
timedepend
order
investig
effect
associ
cumul
exposur
current
exposur
secondari
analys
conduct
differ
specif
caus
death
list
exclud
current
exposur
explanatori
variabl
statist
analys
perform
stata
statist
denmark
server
remot
access
total
patient
male
femal
follow
personyear
present
death
male
femal
studi
popul
patient
mainli
treat
second
gener
antipsychot
drug
patient
male
femal
fewer
treat
typic
antipsychot
drug
patient
male
femal
commonli
prescrib
antipsychot
drug
risperidon
treat
quetiapin
treat
olanzapin
treat
haloperidol
treat
zuclopenthixol
treat
chlorprothixen
treat
total
cardiovascular
relat
death
death
male
femal
present
studi
popul
total
patient
male
femal
cardiovascular
relat
death
expos
antipsychot
point
mean
age
death
expos
group
year
sd
male
year
sd
femal
year
sd
cumul
dosag
antipsychot
treatment
ad
diagnosi
associ
rate
mortal
follow
ddd
hr
ci
p
ddd
hr
ci
p
ddd
hr
ci
p
ddd
hr
ci
p
current
antipsychot
treatment
exposur
increas
mortal
rate
hr
ci
p
result
primari
analysi
depict
fig
secondari
analys
without
current
antipsychot
exposur
explanatori
variabl
shown
tabl
femal
gender
hr
ci
p
well
older
age
dementia
diagnosi
hr
ci
p
decreas
rate
mortal
prescript
antihypertens
drug
lipidlow
drug
oral
antidiabet
insulin
increas
rate
mortal
hr
ci
p
mortal
increas
increas
sever
ad
measur
proxi
marker
number
bed
day
hospit
associ
mortal
rate
one
nine
bed
day
result
hr
ci
p
nine
bed
day
result
hr
ci
p
compar
never
admit
rate
mortal
increas
lower
number
outpati
contact
compar
outpati
contact
one
five
outpati
contact
result
hr
ci
p
six
ten
outpati
contact
hr
ci
p
ten
outpati
contact
hr
ci
p
live
institut
diagnos
dementia
increas
mortal
rate
hr
ci
p
presenc
previou
concurr
psychiatr
disord
increas
rate
mortal
hr
ci
p
well
presenc
diagnos
somat
diseas
hr
ci
p
total
cancer
relat
death
death
male
femal
present
studi
popul
total
male
femal
patient
cancer
relat
death
expos
antipsychot
medic
mean
age
death
expos
group
year
sd
male
year
sd
femal
year
sd
fig
secondari
analys
without
current
antipsychot
exposur
explanatori
variabl
shown
tabl
femal
gender
hr
ci
p
well
older
age
dementia
diagnosi
hr
ci
p
decreas
rate
mortal
prescript
antihypertens
drug
lipidlow
drug
oral
antidiabet
insulin
decreas
rate
mortal
hr
ci
p
mortal
cancer
associ
proxi
measur
ad
sever
number
bed
day
hospit
increas
mortal
rate
one
nine
bed
day
result
hr
ci
p
nine
bed
day
result
hr
ci
p
compar
never
admit
rate
mortal
increas
number
outpati
contact
compar
outpati
contact
one
five
outpati
contact
result
hr
ci
p
six
ten
outpati
contact
hr
ci
p
ten
outpati
contact
hr
ci
p
live
institut
associ
rate
mortal
hr
ci
p
presenc
previou
concurr
psychiatr
disord
increas
rate
mortal
hr
ci
p
well
presenc
diagnos
somat
diseas
hr
ci
p
total
infect
relat
death
death
male
femal
present
studi
popul
among
patient
male
femal
popul
expos
antipsychot
medic
mean
age
death
expos
group
year
sd
male
year
sd
femal
year
sd
regard
death
infect
found
cumul
dosag
antipsychot
treatment
diagnosi
ad
compar
exposur
associ
rate
mortal
follow
fig
secondari
analysi
without
current
antipsychot
exposur
explanatori
variabl
shown
tabl
femal
gender
hr
ci
p
well
older
age
dementia
diagnosi
hr
ci
p
decreas
rate
mortal
prescript
antihypertens
drug
lipidlow
drug
oral
antidiabet
insulin
decreas
rate
mortal
hr
ci
p
mortal
associ
increas
sever
ad
measur
proxi
marker
number
bed
day
hospit
increas
mortal
rate
significantli
one
nine
bed
day
result
hr
ci
p
well
nine
bed
day
result
hr
ci
p
compar
never
admit
rate
mortal
increas
low
number
outpati
contact
compar
outpati
contact
one
five
outpati
contact
result
hr
ci
p
six
ten
outpati
contact
hr
ci
p
ten
outpati
contact
hr
ci
p
live
institut
increas
mortal
rate
hr
ci
p
presenc
previou
concurr
psychiatr
disord
increas
rate
mortal
hr
ci
p
well
presenc
diagnos
somat
diseas
hr
ci
p
twentyeight
intent
selfharm
relat
death
death
present
studi
popul
six
patient
intent
selfharm
relat
death
expos
antipsychot
medic
mean
age
death
expos
group
year
sd
follow
rule
statist
denmark
report
gender
distribut
due
low
number
encount
regard
death
intent
selfharm
find
cumul
dosag
antipsychot
treatment
ad
diagnosi
compar
exposur
associ
rate
mortal
ddd
hr
ci
p
ddd
hr
ci
p
ddd
hr
ci
p
current
antipsychot
treatment
exposur
increas
mortal
rate
significantli
hr
ci
p
compar
exposur
result
primari
analysi
depict
fig
secondari
analysi
without
current
antipsychot
exposur
explanatori
variabl
shown
tabl
prescript
antihypertens
drug
lipidlow
drug
oral
antidiabet
insulin
associ
rate
mortal
hr
ci
p
one
nine
bed
day
result
hr
ci
p
nine
bed
day
result
hr
ci
p
compar
admit
rate
mortal
increas
number
outpati
contact
compar
outpati
contact
one
five
outpati
contact
result
hr
ci
p
six
ten
outpati
contact
hr
ci
p
ten
outpati
contact
hr
ci
p
likewis
live
institut
associ
higher
mortal
rate
hr
ci
p
presenc
previou
concurr
psychiatr
disord
increas
rate
mortal
hr
ci
p
presenc
diagnos
somat
diseas
hr
ci
p
current
studi
allow
us
investig
effect
antipsychot
exposur
nationwid
popul
includ
newli
diagnos
ad
clinician
abl
treat
individu
patient
judg
optim
popul
confirm
result
previou
random
control
trial
cohort
studi
metaanalys
shown
increas
risk
death
associ
current
exposur
antipsychot
treatment
find
consist
signific
investig
caus
death
except
intent
selfharm
could
suggest
current
antipsychot
exposur
affect
mortal
similarli
investig
caus
death
could
also
suggest
current
antipsychot
exposur
marker
sever
ill
tabl
analys
cumul
antipsychot
dosag
ad
diagnosi
initi
includ
current
exposur
explanatori
variabl
show
lowest
cumul
antipsychot
dosag
increas
rate
mortal
wherea
higher
dosag
decreas
rate
mortal
caus
death
patient
current
expos
would
baselin
cumul
dosag
group
zero
ddd
caus
current
exposur
cumul
drug
dosag
group
associ
conduct
analys
without
current
exposur
explanatori
variabl
show
higher
cumul
drug
dosag
associ
increas
mortal
rate
infect
cardiovascular
relat
death
believ
diverg
find
result
collid
bia
could
led
fals
conclus
secondari
analys
without
current
exposur
explanatori
variabl
conduct
find
increas
mortal
rate
associ
cumul
dosag
antipsychot
drug
cardiovascular
infect
relat
death
line
result
studi
studi
cancer
relat
death
associ
higher
cumul
dosag
antipsychot
drug
treatment
find
reassur
although
previou
studi
propos
antipsychot
carcinogen
oppos
disord
investig
studi
popul
select
given
gener
older
yet
die
cancer
relat
ill
studi
suggest
cancer
less
common
patient
diagnos
ad
perhap
result
lack
associ
cumul
antipsychot
dosag
mortal
relat
cancer
secondli
possibl
effect
antipsychot
risk
develop
cancer
would
like
dramat
time
exposur
possibl
cancer
relat
death
could
long
result
patient
die
caus
would
oppos
effect
antipsychot
drug
cardiovascular
relat
death
time
exposur
effect
shorter
shown
studi
patient
dementia
well
psychiatr
disord
specif
background
increas
occurr
cardiovascular
event
unknown
antipsychot
drug
known
increas
risk
hypotens
increas
blood
lipid
well
increas
risk
lower
insulin
sensit
even
diabet
associ
increas
cardiovascular
event
longer
term
review
statist
model
without
current
exposur
see
trend
toward
invers
relationship
antipsychot
cumul
dosag
mortal
find
like
caus
surviv
bia
survivor
treatment
expos
longer
period
therebi
abl
receiv
higher
dosag
medic
altern
interpret
could
clinician
abl
determin
patient
benefit
antipsychot
treatment
continu
treatment
patient
riskbenefit
ratio
posit
sever
shortterm
random
control
trial
conduct
effect
antipsychot
aggress
psychosi
patient
diagnos
alzheim
diseas
predominantli
show
decreas
level
symptom
treatment
explan
result
could
patient
sever
bpsd
antipsychot
drug
efficaci
increas
mortal
rate
current
antipsychot
exposur
could
partli
balanc
lower
mortal
rate
caus
lower
level
bpsd
previou
studi
investig
effect
cumul
dosag
antipsychot
drug
specif
caus
mortal
ad
find
decreas
mortal
appear
studi
schizophrenia
bipolar
affect
disord
effect
cumul
drug
dosag
investig
show
psychiatr
comorbid
increas
rate
mortal
investig
caus
death
includ
intent
selfharm
control
remain
variabl
find
similar
smaller
studi
show
increas
mortal
associ
psychiatr
comorbid
suicid
also
allcaus
mortal
parallel
manner
show
known
somat
diseas
increas
rate
mortal
investig
caus
death
except
intent
selfharm
degre
support
facevalid
statist
model
lastli
show
older
age
diagnosi
well
femal
gender
decreas
rate
mortal
investig
caus
death
find
like
caus
age
diagnosi
prognost
factor
sever
dementia
wherea
latter
find
could
explain
femal
gener
live
longer
compar
male
danish
popul
import
limit
studi
lack
random
increas
risk
systemat
bias
expos
nonexpos
group
although
ad
explanatori
variabl
minim
bia
psychiatr
somat
comorbid
well
sever
disord
unmeasur
differ
expos
unexpos
group
may
affect
result
despit
limit
main
strength
studi
long
followup
time
inclus
elig
patient
nationwid
sampl
current
data
systemat
gather
patient
lost
followup
conclus
found
lifetim
cumul
antipsychot
drug
dosag
compar
exposur
associ
increas
mortal
rate
cardiovascular
infect
relat
death
especi
lower
cumul
dosag
also
show
invers
dose
mortal
relationship
highest
investig
cumul
drug
dosag
associ
decreas
rate
mortal
find
confirm
establish
concern
use
antipsychot
drug
patient
diagnos
ad
also
highlight
need
investig
longterm
effect
treatment
possibl
subgroup
could
benefit
treatment
studi
fund
affili
research
institut
well
grant
psychiatr
research
fund
north
jutland
fund
sourc
role
studi
design
analys
data
present
data
discuss
result
correspond
author
full
access
data
studi
final
respons
decis
submit
public
